MIDAS and HIT-6 French translation: reliability and correlation between tests
- PMID: 17970768
- DOI: 10.1111/j.1468-2982.2007.01461.x
MIDAS and HIT-6 French translation: reliability and correlation between tests
Abstract
The aim was to evaluate the test-retest reliability of the French translation of the Migraine Disability Assessment (MIDAS) and Headache Impact Test (HIT)-6 questionnaires as applied to episodic and chronic headaches and to assess the correlation between these two questionnaires. The MIDAS and HIT-6 questionnaires, which assess the degree of migraine-related functional disability, are widely used in headache treatment clinics. The French translation has not been checked for test-retest reliability. MIDAS involves recall, over the previous 3 months, of the number of days with functional disability with regard to work and to home and social life. HIT-6 involves a more subjective and general assessment of headache-related disability over the previous 4 weeks. We expect that there may be greater impact recall bias for chronic headaches than for episodic headaches and considered it important to be able to determine if the reliability of these questionnaires is equally good for these two patient populations. Given that both questionnaires have the same objective, that of assessing headache impact, it was thought useful to determine if their results might show a correlation and if they could thus be used interchangeably. The study was approved by an external ethics committee. The subjects were patients who regularly visit the Clinique de la Migraine de Montréal, which specializes in the treatment of headaches. The MIDAS and HIT-6 questionnaires were completed by the patients during their regular visit. Twelve days later, the same questionnaires were mailed with a prepaid return envelope. Sixty-five patients were required in both the episodic and chronic headache groups, assuming an 80% questionnaire return rate. One hundred and eighty-five patients were enrolled, and 143 completed the study, 75 with episodic headaches and 68 with chronic headaches. The questionnaire return rate was 78.9%. On average, questionnaires were completed a second time 21 days after the first, with a median of 19 days. The Shrout-Fleiss intraclass correlation coefficients for MIDAS and HIT-6 were, respectively, 0.76 and 0.77 for episodic headaches and 0.83 and 0.80 for chronic headaches. The Pearson correlation coefficient between the MIDAS and HIT-6 questionnaires was 0.48 for episodic headaches and 0.58 for chronic headaches at the first compilation and 0.42 and 0.59 at the second compilation. The test-retest intraclass correlation of the French versions for both MIDAS and HIT-6 questionnaires indicates moderate reliability for episodic headache and substantial reliability for chronic headache. The correlation between the MIDAS and HIT-6 questionnaires is weak for episodic headaches, but approaches a level of 'good' for chronic headaches.
Similar articles
-
Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.Headache. 2004 Sep;44(8):786-93. doi: 10.1111/j.1526-4610.2004.04146.x. Headache. 2004. PMID: 15330825
-
HIT-6 and MIDAS as measures of headache disability in a headache referral population.Headache. 2010 Mar;50(3):383-95. doi: 10.1111/j.1526-4610.2009.01544.x. Epub 2009 Oct 8. Headache. 2010. PMID: 19817883
-
Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.Headache. 2008 Jun;48(6):900-13. doi: 10.1111/j.1526-4610.2007.00953.x. Epub 2007 Nov 28. Headache. 2008. PMID: 18047501 Clinical Trial.
-
Assessing the impact of migraine.Curr Med Res Opin. 2001;17(4):298-309. Curr Med Res Opin. 2001. PMID: 11922404 Review.
-
[Anxiety and depression in children and adolescents with migraine: a review of the literature].Encephale. 2008 Oct;34(5):504-10. doi: 10.1016/j.encep.2007.08.005. Epub 2007 Dec 26. Encephale. 2008. PMID: 19068340 Review. French.
Cited by
-
Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine.Cephalalgia. 2011 Feb;31(3):357-67. doi: 10.1177/0333102410379890. Epub 2010 Sep 6. Cephalalgia. 2011. PMID: 20819842 Free PMC article.
-
Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study.BMJ Open. 2020 Feb 12;10(2):e029855. doi: 10.1136/bmjopen-2019-029855. BMJ Open. 2020. PMID: 32051295 Free PMC article.
-
Reliability and validity of the migraine disability assessment scale among migraine and tension type headache in Iranian patients.Biomed Res Int. 2014;2014:978064. doi: 10.1155/2014/978064. Epub 2014 Jan 16. Biomed Res Int. 2014. PMID: 24527462 Free PMC article.
-
The role of psychosocial risk factors in the burden of headache.J Pain Res. 2019 May 28;12:1733-1741. doi: 10.2147/JPR.S165263. eCollection 2019. J Pain Res. 2019. PMID: 31213885 Free PMC article.
-
Validation of an 8-item self-administered questionnaire for assessing migraine-related sensory hypersensitivities (MHQ-8).J Headache Pain. 2025 May 26;26(1):128. doi: 10.1186/s10194-025-02067-3. J Headache Pain. 2025. PMID: 40414872 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources